Effects of a Food Containing Mushroom Mycelium Powder to Reduce Temporal Discomfort by the Ingestion of Alcohol.
- Conditions
- Healthy adults (susceptible to alcohol)
- Registration Number
- JPRN-UMIN000022975
- Lead Sponsor
- RCT Japan Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Not provided
[1]Individuals whose result of ethanol patch test is DD [2]Individuals using medical products [3]Individuals who is patient or have a history of psychiatric disease, high blood pressure, diabetes, and hyperlipidemia [4]Individuals who take medicine in the past 1 month to remedy disease (except of temporal taking medicine for headache, menstrual pain, or cold) [5]Individuals who have a history of serious hepatopathy, kidney damage, heart disease and hematological disease [6]Individuals who is a patient or have a history of or endocrine disease [7]Individuals whose BMI is over 30kg/m2 [8]Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months [9]Individuals with serious anemia [10]Individuals who are sensitive to test product or other foods, and medical products [11]Individuals who are or are possibly, or are lactating [12]Individuals whose life style will change during the test period (ex. a night shift, travel for a long time, job transfer) [13]Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements to improve liver function in the past 3 month or will ingest those foods during the test period [14]Individuals who participated in other clinical studies in the past 3 months [15]Individuals judged inappropriate for the study by the principal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method *Alcohol Metabolic Capacity [1]Blood alcohol content (First observation, Second observation) [2]Acetaldehyde (First observation, Second observation) [3]Urine creatinine (First observation, Second observation)
- Secondary Outcome Measures
Name Time Method